Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:42 PM
Ignite Modification Date:
2025-12-24 @ 12:42 PM
NCT ID:
NCT02793661
Eligibility Criteria:
Inclusion Criteria:
* Age \> 18 years old
* 15 ml/min/m2 ≤ eGFR ≤ 40 ml/min/m2
* High volume contrast-requiring cardiovascular procedures (estimated contrast volume \> 3 times eGFR value)
* Patient has agreed to all FU testing
Exclusion Criteria:
* Administration of iodine contrast media within 5 days before index procedure
* Emergency procedure or primary PCI
* Patients with pulmonary edema or cardiogenic shock (Killip 3 or 4)
* Hypoxemia defined as SaO2 ≤ 90% and/or PaO2 ≤ 80 mmHg on room air
* Acute Kidney Injury requiring dialysis before the procedure
* Multiple myeloma or cancer treated with chemotherapy
* Subjet is anuric
* Subject has been hospitalized for any change in renal function or has undergone renal replacement therapy (hemodialysis or hemofiltration) within the past month
* Known hypersensitivity to furosemide active ingredient or excipient
* Renal insufficiency with oligoanuria resistant to furosemide or caused by nephrotoxic or hepatotoxic substances
* Pre-coma or coma induced by an hepatic encephalopathy
* Severe hypokalemia, sever hyponatremia, hypovolemia with or without hypotension or dehydration
* Hypersensitivity to sulfamides
* Enrollment in another study unless the study is a registry or unless primary endpoint is reached
* Expected life expectancy \< 1 year
* Pregnant or breastfeeding patient
* Patient under trusteeship or guardianship
* Patient is unable / unwilling to provide an informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02793661
Study Brief:
Protocol Section:
NCT02793661